Astera Labs Valuation

Is ALAB * undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ALAB * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
Mex$713.19
Fair Value
143.7% overvalued intrinsic discount
17
Number of Analysts

Below Fair Value: ALAB * (MX$1738) is trading above our estimate of fair value (MX$713.19)

Significantly Below Fair Value: ALAB * is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ALAB *?

Key metric: As ALAB * is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ALAB *. This is calculated by dividing ALAB *'s market cap by their current revenue.
What is ALAB *'s PS Ratio?
PS Ratio31.7x
SalesUS$490.47m
Market CapUS$15.56b

Price to Sales Ratio vs Peers

How does ALAB *'s PS Ratio compare to its peers?

The above table shows the PS ratio for ALAB * vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average14x
601012 LONGi Green Energy Technology
1.4x10.17%CN¥109.0b
688008 Montage Technology
21.8x27.51%CN¥89.8b
FSLR First Solar
4.4x12.33%US$18.8b
CRDO Credo Technology Group Holding
28.6x31.43%US$12.6b
ALAB * Astera Labs
31.7x24.00%Mex$15.6b

Price-To-Sales vs Peers: ALAB * is expensive based on its Price-To-Sales Ratio (31.7x) compared to the peer average (14.1x).


Price to Sales Ratio vs Industry

How does ALAB *'s PS Ratio compare vs other companies in the Global Semiconductor Industry?

119 CompaniesPrice / SalesEstimated GrowthMarket Cap
No. of Companies142PS02.44.87.29.612+
119 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: ALAB * is expensive based on its Price-To-Sales Ratio (31.7x) compared to the Global Semiconductor industry average (2.9x).


Price to Sales Ratio vs Fair Ratio

What is ALAB *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ALAB * PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio31.7x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate ALAB *'s Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ALAB * forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentMex$1,738.00
Mex$1,962.31
+12.91%
15.14%Mex$2,619.65Mex$1,444.66n/a17
Jun ’26Mex$1,718.00
Mex$1,962.31
+14.22%
15.14%Mex$2,619.65Mex$1,444.66n/a17
May ’26n/a
Mex$2,179.08
0%
17.07%Mex$2,744.36Mex$1,372.18n/a15
Apr ’26n/a
Mex$2,455.32
0%
12.38%Mex$3,014.82Mex$1,648.10n/a15
Mar ’26n/a
Mex$2,554.00
0%
8.82%Mex$3,064.04Mex$2,206.11n/a14
Feb ’26Mex$1,723.96
Mex$2,374.23
+37.72%
15.49%Mex$3,082.59Mex$1,644.05n/a14
Jan ’26Mex$2,784.16
Mex$2,137.05
-23.24%
15.00%Mex$2,850.42Mex$1,605.87n/a13
Dec ’25n/a
Mex$2,041.11
0%
9.71%Mex$2,428.78Mex$1,619.18n/a13
Nov ’25n/a
Mex$1,442.66
0%
14.22%Mex$1,699.20Mex$939.56n/a12
Oct ’25n/a
Mex$1,265.19
0%
15.90%Mex$1,589.28Mex$878.78n/a12
Sep ’25n/a
Mex$1,265.19
0%
15.90%Mex$1,589.28Mex$878.78n/a12
Aug ’25n/a
Mex$1,482.40
0%
5.05%Mex$1,655.98Mex$1,436.31n/a11
Jul ’25Mex$1,071.73
Mex$1,482.40
+38.32%
5.05%Mex$1,655.98Mex$1,436.31n/a11
Jun ’25n/a
Mex$1,482.40
0%
5.05%Mex$1,655.98Mex$1,436.31Mex$1,718.0011
May ’25n/a
Mex$1,439.06
0%
5.74%Mex$1,671.56Mex$1,353.96n/a11
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
Mex$1.88k
Fair Value
7.4% undervalued intrinsic discount
17
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/13 10:03
End of Day Share Price 2025/06/10 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Astera Labs, Inc. is covered by 16 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas O'MalleyBarclays
Junyun ChenCitic Securities Co., Ltd.
Atif MalikCitigroup Inc